TCL Archive Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients. April 9, 2010
TCL Archive ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent. March 14, 2008
TCL Archive OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million December 8, 1978
TCL Archive NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved February 26, 1993
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005